scholarly journals Research Article Association study between GSTM1 and GSTT1 genotypes and other possible risk factors in prostate cancer patients in a population from southwest Bahia, Brazil

2019 ◽  
Vol 18 (3) ◽  
Author(s):  
L.C.F. de Souza ◽  
T.L.S. Brito ◽  
A.T. Almeida ◽  
Y.P. Muniz ◽  
P.B. Nishiyama ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Association Study ◽  
Cancer Patients ◽  
Research Article

214: Incidence and Risk Factors of Symptomatic DVT in Prostate Cancer Patients Undergoing Laparoscopic Radical Prostatectomy

2006 ◽  
Vol 175 (4S) ◽  
pp. 70-71
Author(s):  
Fernando P. Secin ◽  
Clément-Claude Abbou ◽  
Inderbir S. Gill ◽  
Georges Fournier ◽  
Thierry Piéchaud ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Radical Prostatectomy ◽  
Cancer Patients ◽  
Laparoscopic Radical Prostatectomy

scholarly journals MO27-2 Risk factors for metastasis in prostate cancer patients: A systematic review

2021 ◽  
Vol 32 ◽  
pp. S315
Author(s):  
Billy Susanto ◽  
Griffin Geraldo ◽  
Jennifer Jesse Limanto ◽  
Andree Kurniawan
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Systematic Review ◽  
Cancer Patients

scholarly journals Investigation of risk factors for prostate cancer patients with bone metastasis based on clinical data

2010 ◽  
Vol 1 (4) ◽  
pp. 635-639 ◽  
Author(s):  
YOSHIAKI YAMADA ◽  
KATSUYA NARUSE ◽  
KOGENTA NAKAMURA ◽  
TOMOHIRO TAKI ◽  
MOTOI TOBIUME ◽  
...  
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Bone Metastasis ◽  
Cancer Patients ◽  
Clinical Data

Analysis of risk factors for prostate cancer patients

2015 ◽  
Vol 7 (4) ◽  
pp. 365
Author(s):  
Khaled S. Alqahtani ◽  
Shankar Srinivasan ◽  
Dinesh P. Mital ◽  
Syed Haque
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Cancer Patients

scholarly journals Assessment and Mitigation of Cardiovascular Risk for Prostate Cancer Patients: A review of the evidence

2021 ◽  
Author(s):  
Patrick Davey ◽  
Kyriacos Alexandrou
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Cardiovascular Risk ◽  
Cancer Patients ◽  
Molecular Mechanisms ◽  
Risk Mitigation ◽  
Current Evidence ◽  
Gnrh Agonists ◽  
Gnrh Antagonists ◽  
Co Morbidity

Abstract Background: Cardiovascular disease (CVD) is a common co-morbidity in patients with prostate cancer. In this review, we summarise the published literature on the association of cardiovascular risk with androgen deprivation therapy (ADT) treatment and explore the potential differences between the gonadotropin-releasing hormone (GnRH) agonists and antagonists and the molecular mechanisms that may be involved. We also provide a practical outlook on the identification of underlying CV risk and explore the different stratification tools available. Results: While not definitive, the current evidence suggests that GnRH antagonists may be associated with lower rates of certain CV events vs agonists, particularly in patients with pre-existing CVD. We have reached this conclusion as the highest-grade evidence from randomised clinical trials comparing GnRH agonists verses antagonists is uniform in finding lower CV event rates with GnRH antagonists. Risk reduction strategies such as lifestyle advice, consideration of ADT modality, and co-medications may help to reduce CV risk factors and improve outcomes in prostate cancer patients receiving ADT. Conclusions: Given all the data that is currently available, identification of baseline CV risk factors may be key to risk mitigation in patients with prostate cancer receiving ADT.

scholarly journals Current Management of Membranous Urethral Strictures Due to Radiation

2021 ◽  
Vol 8 ◽  
Author(s):  
Marjan Waterloos ◽  
Francisco Martins ◽  
Wesley Verla ◽  
Luis Alex Kluth ◽  
Nicolaas Lumen
Keyword(s):  
Prostate Cancer ◽  
Risk Factors ◽  
Functional Outcome ◽  
Cancer Cells ◽  
Cancer Patients ◽  
Surrounding Tissue ◽  
Current Management ◽  
Urethral Strictures ◽  
Literature Overview ◽  
Radiation Induced

Radiotherapy is a frequently used treatment for prostate cancer. It does not only causes the intended damage to cancer cells, but also affects healthy surrounding tissue. As a result radiation-induced urethral strictures occur in 2.2% of prostate cancer patients. Management of urethral strictures is challenging due to the presence of poor vascularized tissue for reconstruction and the proximity of the sphincter, which can impair the functional outcome. This review provides a literature overview of risk factors, diagnostics and management of radiation-induced urethral strictures.

Sign in / Sign up

Export Citation Format

Share Document